User:Tilman Schirmer/Sandbox 201
From Proteopedia
(Difference between revisions)
(→1.5 Allosteric product binding site) |
(→1.5 Allosteric product binding site) |
||
| Line 37: | Line 37: | ||
=== 1.5 Allosteric product binding site === | === 1.5 Allosteric product binding site === | ||
| - | <applet load='2v0n' size='300' frame='true' align='right' caption='Insert caption here' /> | + | <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/5gp/1' size='300' frame='true' align='right' caption='Insert caption here' /> |
---- | ---- | ||
| - | ==== | + | ==== C-di-GMP ==== |
<scene name='User:Tilman_Schirmer/Sandbox_201/5gp/1'>5GP</scene> | <scene name='User:Tilman_Schirmer/Sandbox_201/5gp/1'>5GP</scene> | ||
---- | ---- | ||
| - | ==== | + | ==== Primary inhibition site (Ip) ==== |
| - | <scene name='User:Tilman_Schirmer/Sandbox_201/Primary_inhibition_site/2'> | + | <scene name='User:Tilman_Schirmer/Sandbox_201/Primary_inhibition_site/2'>Primary inhibition site</scene> |
| - | <scene name='User:Tilman_Schirmer/Sandbox_201/Primary_inhibition_site_5gp/1'> | + | <scene name='User:Tilman_Schirmer/Sandbox_201/Primary_inhibition_site_5gp/1'>Primary inhibition site + 5GP</scene> |
---- | ---- | ||
| - | ==== | + | ==== Secondary inhibition site (Is) ==== |
| + | <scene name='User:Tilman_Schirmer/Sandbox_201/Secondary_inhibition_site/1'>Secondary inhibition site</scene> | ||
| + | |||
| + | <scene name='User:Tilman_Schirmer/Sandbox_201/Secondary_inhibition_site_5gp/1'>Secondary inhibition site</scene> | ||
| + | |||
| + | ---- | ||
| + | |||
| + | ==== Primary and secondary inhibition sites ==== | ||
| + | |||
| + | <scene name='User:Tilman_Schirmer/Sandbox_201/Prim_sec_inhibition_site/1'>Primary and secondary inhibition sites</scene> | ||
| + | |||
| + | <scene name='User:Tilman_Schirmer/Sandbox_201/Prim_sec_inhibition_site_5gp/1'>Primary and secondary inhibition sits = 5GP</scene> | ||
---- | ---- | ||
Revision as of 13:02, 19 June 2009
Diguanylate cyclases
Contents |
1. PleD
1.1 Intro
1.2 Domain structure
1.3 Protomer
|
: , ,
1.4 Substrate binding site
|
1.5 Allosteric product binding site
|
C-di-GMP
Primary inhibition site (Ip)
Secondary inhibition site (Is)
Primary and secondary inhibition sites
1.6 Two conformations
|
|
1.7 Non-activated conformation
|
: , ,
1.8 Activated conformation
|


